Hansa Biopharma AB
OTC:HNSBF
Hansa Biopharma AB
OTC:HNSBF
Price:
2.9
USD
Market Cap:
$316.6m
Wall Street
Price Targets
HNSBF Price Targets Summary
Hansa Biopharma AB
Hansa Biopharma AB
Wall Street analysts forecast HNSBF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
HNSBF
is 7.69 USD
with a low forecast of 3.49 USD and a high forecast of 10.69 USD.
Lowest
Price Target
3.49
USD
20% Upside
Average
Price Target
7.69
USD
165% Upside
Highest
Price Target
10.69
USD
269% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HNSBF's stock price target?
Price Target
7.69
USD
7.69
USD
According to Wall Street analysts, the average 1-year price target for
HNSBF
is 7.69 USD
with a low forecast of 3.49 USD and a high forecast of 10.69 USD.
What is Hansa Biopharma AB's Revenue forecast?
Projected CAGR
76%
76%
For the last 14 years the
compound annual growth rate for
Hansa Biopharma AB's revenue is
44%.
The projected
CAGR
for the next 3 years is
76%.
